Psoriasis is a chronic autoimmune condition that affects approximately 2% of the population. This condition causes the rapid buildup of skin cells which results in scaling on the surface of the skin.

While psoriasis is non-contagious, it can be both physically and emotionally distressing for those who suffer from it.

Children with psoriasis often feel self-conscious about their appearance, which can lead to anxiety and social isolation. Furthermore, children who experience psoriasis may also have trouble sleeping and experience pain or discomfort.

Fortunately, there is some good news for children with psoriasis. Janssen Cilag, a pharmaceutical company, has developed a new treatment designed specifically for children.

This treatment offers hope to children and their families who are struggling with the physical and emotional side effects of psoriasis.

Understanding Psoriasis

Prior to discussing Janssen Cilag’s latest development for psoriasis, it is crucial to understand the condition itself.

Psoriasis is a chronic skin condition that occurs when the immune system mistakenly attacks healthy skin cells.

As a result, the skin cells rapidly increase, causing skin buildup that leads to a wide range of symptoms such as itching, redness, and scaling.

While psoriasis affects people of all ages, it often develops between the ages of 15 and 35. Approximately 10-30% of all psoriasis cases occur in children.

Challenges for Children with Psoriasis

Psoriasis can be particularly challenging for children as they navigate social situations and develop self-esteem. Children with psoriasis might feel embarrassed, avoid social situations, and feel isolated from peers.

They may struggle with anxiety about their appearance and experience bullying.

In addition, children with psoriasis might deal with physical discomfort associated with the condition such as itching, tenderness, and soreness. Some children may also experience loss of sleep, fatigue, and depression.

Traditional Treatment Options

There are several traditional treatment options available for psoriasis. These treatments fall into three main categories: topical treatments, phototherapy, and systemic medications.

Topical treatments, such as ointments and creams, are applied directly to the skin and work by reducing inflammation and scaling.

While these treatments can be effective for some individuals with mild to moderate psoriasis, they often require consistent use and may have undesirable side effects such as skin thinning and the risk of infection.

Phototherapy involves exposing the skin to ultraviolet light, which can help to slow down the growth of skin cells. This type of treatment can be time-consuming and requires multiple visits to a dermatologist’s office.

Systemic medications, such as biologics and immunosuppressants, are used to treat both moderate and severe psoriasis.

These treatments are prescribed by a dermatologist or healthcare provider and can have potentially serious side effects such as an increased risk of infection and liver damage.

Janssen Cilag’s New Development

Janssen Cilag’s new development offers hope to families who are dealing with psoriasis in children. The pharmaceutical company has developed a topical cream that targets children with mild to moderate psoriasis.

In a recent phase III clinical trial, this treatment demonstrated efficacy and safety in improving the symptoms of psoriasis in children between the ages of 2 and 18.

The treatment works by reducing inflammation and scaling, which results in smoother and healthier-looking skin.

Unlike other systemic treatments that require ongoing use and have potential side effects, Janssen Cilag’s treatment is a topical cream that can be applied directly to the skin.

The development of this treatment is a significant step forward for children with psoriasis. The cream can be easily applied at home and does not require multiple visits to a dermatologist’s office or systemic medication.

Possible Side Effects

While Janssen Cilag’s development has been shown to be safe and effective, there are still some potential side effects that parents should be aware of.

The most common side effects of this topical cream include skin irritation, itching, and burning. Parents should also be aware of potential infection, which can occur if the skin is not properly cared for.

If parents notice any significant changes to their child’s skin or experience any unusual side effects, they should speak with their healthcare provider immediately.

Conclusion

Janssen Cilag’s latest development offers new hope for children with psoriasis. This breakthrough topical cream represents a significant improvement in treating psoriasis in children.

By reducing irritation and scaling, this treatment can help alleviate the physical and emotional burden experienced by children with psoriasis.

While it is crucial to be aware of potential side effects, the benefits of this treatment outweigh the risks. Overall, Janssen Cilag’s latest development is a promising solution for families dealing with psoriasis in children.